Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

85.59USD
11 Dec 2017
Change (% chg)

$-0.01 (-0.01%)
Prev Close
$85.60
Open
$85.53
Day's High
$86.67
Day's Low
$85.21
Volume
395,645
Avg. Vol
392,687
52-wk High
$91.73
52-wk Low
$63.69

Chart for

About

Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $12,055.97
Shares Outstanding(Mil.): 140.84
Dividend: 0.16
Yield (%): 0.75

Financials

  Industry Sector
P/E (TTM): -- 32.13 15.67
EPS (TTM): -- -- --
ROI: -- 15.10 34.62
ROE: -- 16.59 16.00

BRIEF-Perrigo Announces The Launch Of An AB Rated Generic Version Of Mycolog II Cream

* PERRIGO ANNOUNCES THE LAUNCH OF AN AB RATED GENERIC VERSION OF MYCOLOG II CREAM Source text for Eikon: Further company coverage:

Nov 27 2017

BRIEF-Perrigo Company ‍Launch AB Rated Generic Version Of Exalgo 32mg

* PERRIGO COMPANY PLC - ‍LAUNCH OF AN AB RATED GENERIC VERSION OF EXALGO 32MG EXTENDED RELEASE TABLETS C-II​ Source text for Eikon: Further company coverage:

Nov 27 2017

BRIEF-Perrigo Company completes divestiture of API business for $110 million

* Perrigo Company completes divestiture of API business for $110 million Source text for Eikon: Further company coverage:

Nov 21 2017

BRIEF-Perrigo Q3 GAAP EPS $0.31

* Perrigo Company PLC reports third quarter 2017 financial results

Nov 09 2017

BRIEF-Perrigo announces tentative FDA approval for a first-to-file generic version of Picato Gel 0.05 pct

* Perrigo announces tentative fda approval for a first-to-file generic version of Picato Gel 0.05 pct

Nov 02 2017

BRIEF-Perrigo announces patent litigation settlement for generic version of Onexton® Gel

* Perrigo announces patent litigation settlement for the generic version of Onexton® Gel

Oct 26 2017

BRIEF-Perrigo announces tentative FDA approval for generic version of Picato gel.015%

* Perrigo announces tentative FDA approval for a first-to-file generic version of Picato Gel .015%

Oct 24 2017

BRIEF-Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets

* Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets

Sep 21 2017

BRIEF-Perrigo announces tentative FDA approval for generic version of Acanya gel

* Perrigo announces tentative FDA approval for the generic version of Acanya® gel

Sep 18 2017

BRIEF-Perrigo announces final FDA approval and settlement for the store brand OTC equivalent of Nexium 24hr capsules

* Perrigo announces final FDA approval and settlement for the store brand OTC equivalent of Nexium 24hr capsules

Aug 21 2017

Earnings vs. Estimates